Nivolumab and Ipilimumab in Advanced Mismatch Repair–Deficient/Microsatellite Instability–High Noncolorectal CancersMatteo S. Carlino, Oliver Klein, Ashray Gunjur et al.|JAMA Oncology|2025Cited by 5
998MO Nivolumab and ipilimumab combination treatment in advanced dMMR/MSI-H noncolorectal cancers: Results from the phase II MoST-CIRCUIT studyOliver Klein, M.S. Carlino, Bo Gao et al.|Annals of Oncology|2024Cited by 1